Ana-Eugenia Rodríguez-Vicente

14PUBLICATIONS
83CO-AUTHORS
Life historiesHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 14, 2025
Lifetime Variations in Prolactin Expression in the Hippocampus and Dentate Gyrus of the Rat.

Marta Carretero-Hernández, Elisa Herráez, Leonardo Catalano-Iniesta

|Apr 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker.

Birna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton

|Jan 22, 2025
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

|Dec 24, 2022
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.

Larry Mansouri, Birna Thorvaldsdottir, Lesley-Ann Sutton

|Apr 26, 2022
TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features.

Claudia Pérez-Carretero, María Hernández-Sánchez, Teresa González

|Jul 10, 2021
Biological significance of monoallelic and biallelic BIRC3 loss in del(11q) chronic lymphocytic leukemia progression.

Miguel Quijada-Álamo, María Hernández-Sánchez, Ana-Eugenia Rodríguez-Vicente

Pageof 3

Frequent Collaborators

6 joint publications

María Hernández-Sánchez

5 joint publications

Rocío Benito

4 joint publications

Claudia Pérez-Carretero

4 joint publications

Isabel González-Gascón-Y-Marín